In conclusion, TET1 plays a therapeutically significant role in multiple disease models, such as acute kidney injury and Alzheimer’s disease, highlighting its notable research value and broad clinical application potential. This evidence concerns the gene TET1 and early-onset autosomal dominant Alzheimer disease.